Virax Biolabs (VRAX) said Monday it has extended its exclusive distribution agreement with Cosmos Health (COSM) to commercialize Mpox virus test kits in Gulf countries.
Shares of Virax rose more than 38% in recent premarket activity. Cosmos Health added over 6% recently.
Virax had previously signed an exclusive distribution deal for Greece and Cyprus, with a non-exclusive agreement to distribute throughout Europe, the company said. The latest extension covers the Gulf Cooperation Council, including Bahrain, Saudi Arabia and the United Arab Emirates.
Financial details of the contract extension were not disclosed.
Price: 3.5900, Change: +1.00, Percent Change: +38.61
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。